Impact of proton pump inhibitors on clinical outcomes in patients after acute myocardial infarction: a propensity score analysis from China Acute Myocardial Infarction (CAMI) registry

BACKGROUND: Proton pump inhibitors (PPIs) are recommended by the latest guidelines to reduce the risk of bleeding in acute myocardial infarction (AMI) patients treated with dual antiplatelet therapy (DAPT). However, previous pharmacodynamic and clinical studies have reported controversial results on...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:J Geriatr Cardiol
Główni autorzy: SHI, Wen-Ce, GAO, Si-De, YANG, Jin-Gang, FAN, Xiao-Xue, NI, Lin, SU, Shu-Hong, YU, Mei, YANG, Hong-Mei, YU, Meng-Yue, YANG, Yue-Jin, on behalf of China Acute Myocardial In-farction (CAMI) Registry study group
Format: Artigo
Język:Inglês
Wydane: Science Press 2020
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7729183/
https://ncbi.nlm.nih.gov/pubmed/33343644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11909/j.issn.1671-5411.2020.11.008
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy